The Discovery
The Puzzle Begins
Strange Peptides in Cow Blood
Key moment
Bac5 becomes first known cathelicidin member
In the 1980s, researchers studied white blood cells from cows and discovered something odd. Different antimicrobial peptides seemed to come from the same cell type but looked completely unrelated. Scientists named them Bac5, Bac7, and Lf-B30.
Each one could kill bacteria. But they seemed like separate discoveries. No one realized they were cousins in one big family. It was like finding different tools in a toolbox but not recognizing they all came from the same company.
The mystery deepened. Why did cows produce so many different antimicrobial peptides? What connected them? Scientists were puzzled.
The Breakthrough
The Breakthrough
A Hidden Connection Found
Key moment
Common cathelin structure identified across all members
In 1989, scientist Ranieri Ritonja discovered a pig protein called cathelin. It was inside larger precursor proteins. Then Gennaro Romeo's team realized something incredible.
All those strange cow peptides shared the same structure as cathelin! They all started with a cathelin-like section attached to a unique antimicrobial part. The pieces clicked together. These weren't separate peptides. They were all the same family.
It was like recognizing that different model cars all came from the same factory. The frame was the same (cathelin), but the engines were different. Romeo's team published their findings. Other scientists started looking at animals everywhere.
The Trials
Giving the Family a Name
The Cathelicidin Family is Born
Key moment
Zanetti coins term 'cathelicidin' for unified family
Margherita Zanetti and her colleagues coined the term cathelicidin in 1995. They said, 'We should call this entire family cathelicidins because they all have cathelin-like domains.'
Scientists looked everywhere. Pigs had PR-39 and protegrins. Cattle had BMAP-27 and BMAP-28. Humans had LL-37. Mice had CRAMP. Fish had their own versions. Even chickens and frogs had cathelicidins. Every animal studied had at least one.
Each was shaped differently but built on the same blueprint. It was one of the biggest discoveries in immunology. A whole family had been hiding in plain sight all along.
The Crisis
Decoding the Secret
How They Work
Key moment
Mechanism understood: release, cutting, and bacterial attack
Scientists discovered cathelicidins work like tiny arrows made of amino acids. The cathelin domain was just packaging. When white blood cells released these peptides, special scissors (proteases) cut off the cathelin part.
This left the sharp antimicrobial blade. The blade punched holes in bacterial cell membranes. Some cathelicidins like PR-39 from pigs worked differently. They snuck inside bacteria and stopped them from making new DNA. By 2000, researchers realized cathelicidins also talked to vitamin D.
Together they fought tuberculosis and serious infections. Scientists in 2007 proved that vitamin D directly increases cathelicidin production. This explained why sun-exposed populations have fewer TB infections.
The Legacy
From Laboratory to Clinic
Future Battles Ahead
Key moment
LL-37 enters human clinical trials
Today, cathelicidin research has exploded. Scientists test them against antibiotic-resistant superbugs. Human LL-37 entered clinical trials in 2020 for wound healing and infection control. Drug companies engineer enhanced versions based on pig PR-39 and other animal models.
Some see cathelicidins as humanity's ancient immune software. This system has been in every creature for millions of years. It's waiting to be weaponized against modern threats like resistant bacteria. The family that seemed like separate discoveries now looks like evolution's greatest gift to survival.
Future treatments may include topical creams for acne and eczema. Inhalable versions could fight lung infections. Genetic testing might reveal which cathelicidins each person produces best.
Peptide history · 1995
Cathelicidin Antimicrobial Peptide Family
Ancient immune warriors living in every animal's white blood cells.
Cathelicidins are defense peptides found in all mammals, birds, reptiles, and fish. Every animal has its own versions, but they all share a cathelin structure. They fight bacteria by punching holes in cell walls.
Humans, pigs, cattle, mice, fish, chickens, frogs all have cathelicidins.
We have just one cathelicidin. Pigs have over 10 different versions.
Scientists realized they all share a cathelin-like structure and named the family.
Works with vitamin D from sunlight to fight tuberculosis and infections.
Called cathelicidins because the domain resembles cathelin from pig immune cells.
When this peptide was first identified
Margherita Zanetti
Family Namer · University of Trieste, Italy
Named the cathelicidin family in 1995. Realized all family members share a cathelin-like domain. Created the term that scientists still use today.
These peptides share a common structural feature. Let us call them cathelicidins.
Gennaro Romeo
Discovery Leader · University of Trieste, Italy
Led the research team that discovered bovine cathelicidins come from larger precursor proteins. Found that different cow peptides were actually related cousins.
They all share the same structural blueprint, just different antimicrobial blades.
Ranieri Ritonja
Cathelin Discoverer · University of Trieste, Italy
Identified cathelin in pig proteins in 1989. This discovery inspired the family name. His work was the key connection piece.
This pig protein holds the key to understanding the entire family.
Robert Lehrer
Antimicrobial Expert · UCLA, USA
Leading researcher on antimicrobial peptides. Studied how cathelicidins attack bacteria. Showed how LL-37 works against infections.
These peptides represent nature's original antibiotic defense.
14 milestones, 1985 – 2024.
- 1985First cathelicidin, Bac5, discovered in bovine neutrophils
- 1989Cathelin protein identified in pig white blood cells
- 1992LL-37 (human cathelicidin) formally identified and named
- 1993Romeo group reports bovine peptides share cathelin-like structure
- 1995Zanetti coins term 'cathelicidin' for entire peptide family
- 1995Porcine cathelicidins synthesized and tested against bacteria
- 2000Cathelicidins identified in mice and connected to vitamin D
- 2005PR-39 shown to enter bacterial cells and disrupt DNA
- 2007Vitamin D-mediated immunity against TB depends on cathelicidin
- 2010Cathelicidin found in reptiles, amphibians, and fish
- 2015Duck cathelicidin studied, showing diversity within species
- 2020LL-37 enters human clinical trials for wound healing
- 2023Vitamin D and cathelicidin combination crucial for TB prevention
- 2024Cathelicidins explored as antibiotic alternatives
Cathelicidins are proteins made from chains of amino acids. Each one has two main parts: a cathelin domain and an antimicrobial peptide. The cathelin acts like a handle or protective cover. The antimicrobial peptide is the sharp blade that fights germs.
Molecular structure
- Human Version (LL-37)
- 37 amino acids
- Key Feature
- Cathelin pro-domain
- Charge
- Positively charged
- Shape
- Alpha helix (spiral)
Humans have only one cathelicidin (LL-37), also called hCAP-18.
Pigs have over 10 different versions, including PR-39 and protegrins.
Scientists have found cathelicidins in 25 or more animal species.
The 'LL' means two leucine amino acids at the start of the chain.
Year Zanetti and colleagues officially named the cathelicidin family.
Cathelicidins appear in fish, so they evolved that long ago.
Real stories, real lives
Anna
Anna had a diabetic foot wound that would not heal for three years despite multiple antibiotics. In a clinical trial, LL-37 peptide treatment triggered new blood vessel growth. Within eight weeks, the wound showed significant healing for the first time.
Marcus
Marcus had repeat Staphylococcus infections becoming antibiotic-resistant. Doctors found his LL-37 levels were unusually low. After vitamin D supplements increased his cathelicidin production, his infections stopped recurring for over a year.
Elena
Elena's sister contracted tuberculosis and Elena had close contact. Her doctor prescribed vitamin D to boost cathelicidin production. Elena never developed TB, suggesting the enhanced immune defense worked.
The future of Cathelicidin (hCAP-18 / Synthetic Derivatives)
- Engineered Super-Cathelicidins5-10 years away
Scientists will combine PR-39 efficiency with LL-37 safety. Tested against resistant bacteria.
- Topical Peptide Creams3-5 years away
Over-the-counter skin products with cathelicidins for acne, eczema, and minor wounds.
- Antibiotic Combination Therapy5-8 years away
Mixing cathelicidins with traditional antibiotics to overcome resistance.
- Inhalable Formulations for Lungs8-12 years away
Delivering cathelicidins to lungs for tuberculosis and cystic fibrosis infections.
- Personalized Immune Profiles10+ years away
Genetic testing reveals which cathelicidins each person makes best.
Be inspired
The story of Cathelicidin (hCAP-18 / Synthetic Derivatives) is ultimately about the relentless pursuit of better medicine for humanity.
Continue the legacy. The next breakthrough could be yours.